Cameroon
ACCRA, Ghana -- The lives of almost 4 million women, newborns, and children in sub-Saharan Africa could be saved every year if well-established, affordable health care interventions reached 90 perc
Irvine, Calif. -- Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.
KIGALI, Rwanda (July 27, 2009) -- Government health officials from 13 African countries today launched the first-ever push for accreditation of the continent's medical laboratories, starting a process that the World Health Organization (WHO) and the U.S. Government believe will be an historic step to strengthen health systems and lead to better care for patients.
Chicago -- An international consortium has found that wild chimpanzees naturally infected with Simian Immunodeficiency Viruses (SIV) -- long thought to be harmless to the apes -- can contract an AIDS-like syndrome and die as a result. The findings are published in the July 23 edition of the journal Nature.
ROME, ITALY -- As rapidly rising temperatures in Africa threaten to scorch local varieties of maize and other food staples, the food security of many Africans will depend on farmers in one country gaining access to climatically suitable varieties now being cultivated in other African nations, and beyond, according to a peer-reviewed study published in Global Environmental Change.
TEMPE, Ariz. ? The International Institute for Species Exploration at Arizona State University and an international committee of taxonomists ? scientists responsible for species exploration and classification ? today announce the top 10 new species described in 2008.
Access to antiretroviral therapies for people living with HIV in the developing countries is a major world health priority. One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet. These combinations, however, have never been fully evaluated and therefore raise questions as to their efficacy and safety. A clinical trial, conducted in Cameroon by IRD researchers working with other organizations and supported by the ANRS (1), has demonstrated that one of the most common combinations currently deployed in Africa, using nevirapine, stavudine and lamivudine, satisfies these criteria. The full results, published and discussed in the journal The Lancet, confirmed that this generic tritherapy can be used as a basic treatment in the developing countries.
